Close menu
  • News
  • Why PRWeb
  • Contact
    • Send a Release
    • Sign up
    • Log in
    • Resources
    • RSS
    • GDPR
    • 2 News in Focus
    • 5 Business & Money
    • 5 Science & Tech
    • 5 Lifestyle & Health
    • 0 Policy & Public Interest
    • 1 People & Culture
    • Send a Release
    • Sign up
    • Log in
    • Resources
    • RSS
    • GDPR
    • Send a Release
    • Sign up
    • Log in
    • Resources
    • RSS
    • GDPR
    • Send a Release
    • Sign up
    • Log in
    • Resources
    • RSS
    • GDPR
    Close submenu (News in Focus)News in Focus
    • Browse All News
    • Multimedia Gallery
    Close submenu (Business & Money)Business & Money
    • Auto & Transportation
    • Business Technology
    • Entertain­ment & Media
    • Financial Services & Investing
    • General Business
    Close submenu (Science & Tech)Science & Tech
    • Consumer Technology
    • Energy & Natural Resources
    • Environ­ment
    • Heavy Industry & Manufacturing
    • Telecomm­unications
    Close submenu (Lifestyle & Health)Lifestyle & Health
    • Consumer Products & Retail
    • Entertain­ment & Media
    • Health
    • Sports
    • Travel
    Close submenu (Policy & Public Interest)Policy & Public Interest
    Close submenu (People & Culture)People & Culture
    • People & Culture
    Accessibility Statement Skip Navigation
    • Why PRWeb
    • How It Works
    • Who Uses It
    • Pricing
    • Login
    • GDPR
    • Create a Free Account
    Return to PRWeb homepage
    • News
    • Resources
    • Contact
    When typing in this field, a list of search results will appear and be automatically updated as you type.

    Searching for your content...

    No results found. Please change your search terms and try again.
    • News in Focus
        • Browse News Releases

        • All News Releases
        • Multimedia Gallery

        • All Multimedia
        • All Photos
        • All Videos
    • Business & Money
        • Auto & Transportation

        • Aerospace, Defense
        • Air Freight
        • Airlines & Aviation
        • Automotive
        • Maritime & Shipbuilding
        • Railroads and Intermodal Transportation
        • Supply Chain/Logistics
        • Transportation, Trucking & Railroad
        • Travel
        • Trucking and Road Transportation
        • View All Auto & Transportation

        • Business Technology

        • Blockchain
        • Broadcast Tech
        • Computer & Electronics
        • Computer Hardware
        • Computer Software
        • Data Analytics
        • Electronic Commerce
        • Electronic Components
        • Electronic Design Automation
        • Financial Technology
        • High Tech Security
        • Internet Technology
        • Nanotechnology
        • Networks
        • Peripherals
        • Semiconductors
        • View All Business Technology

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Financial Services & Investing

        • Accounting News & Issues
        • Acquisitions, Mergers and Takeovers
        • Banking & Financial Services
        • Bankruptcy
        • Bond & Stock Ratings
        • Conference Call Announcements
        • Contracts
        • Cryptocurrency
        • Dividends
        • Earnings
        • Earnings Forecasts & Projections
        • Financing Agreements
        • Insurance
        • Investments Opinions
        • Joint Ventures
        • Mutual Funds
        • Private Placement
        • Real Estate
        • Restructuring & Recapitalization
        • Sales Reports
        • Shareholder Activism
        • Shareholder Meetings
        • Stock Offering
        • Stock Split
        • Venture Capital
        • View All Financial Services & Investing

        • General Business

        • Awards
        • Commercial Real Estate
        • Corporate Expansion
        • Earnings
        • Environmental, Social and Governance (ESG)
        • Human Resource & Workforce Management
        • Licensing
        • New Products & Services
        • Obituaries
        • Outsourcing Businesses
        • Overseas Real Estate (non-US)
        • Personnel Announcements
        • Real Estate Transactions
        • Residential Real Estate
        • Small Business Services
        • Socially Responsible Investing
        • Surveys, Polls and Research
        • Trade Show News
        • View All General Business

    • Science & Tech
        • Consumer Technology

        • Artificial Intelligence
        • Blockchain
        • Cloud Computing/Internet of Things
        • Computer Electronics
        • Computer Hardware
        • Computer Software
        • Consumer Electronics
        • Cryptocurrency
        • Data Analytics
        • Electronic Commerce
        • Electronic Gaming
        • Financial Technology
        • Mobile Entertainment
        • Multimedia & Internet
        • Peripherals
        • Social Media
        • STEM (Science, Tech, Engineering, Math)
        • Supply Chain/Logistics
        • Wireless Communications
        • View All Consumer Technology

        • Energy & Natural Resources

        • Alternative Energies
        • Chemical
        • Electrical Utilities
        • Gas
        • General Manufacturing
        • Mining
        • Mining & Metals
        • Oil & Energy
        • Oil and Gas Discoveries
        • Utilities
        • Water Utilities
        • View All Energy & Natural Resources

        • Environ­ment

        • Conservation & Recycling
        • Environmental Issues
        • Environmental Policy
        • Environmental Products & Services
        • Green Technology
        • Natural Disasters
        • View All Environ­ment

        • Heavy Industry & Manufacturing

        • Aerospace & Defense
        • Agriculture
        • Chemical
        • Construction & Building
        • General Manufacturing
        • HVAC (Heating, Ventilation and Air-Conditioning)
        • Machinery
        • Machine Tools, Metalworking and Metallurgy
        • Mining
        • Mining & Metals
        • Paper, Forest Products & Containers
        • Precious Metals
        • Textiles
        • Tobacco
        • View All Heavy Industry & Manufacturing

        • Telecomm­unications

        • Carriers and Services
        • Mobile Entertainment
        • Networks
        • Peripherals
        • Telecommunications Equipment
        • Telecommunications Industry
        • VoIP (Voice over Internet Protocol)
        • Wireless Communications
        • View All Telecomm­unications

    • Lifestyle & Health
        • Consumer Products & Retail

        • Animals & Pets
        • Beers, Wines and Spirits
        • Beverages
        • Bridal Services
        • Cannabis
        • Cosmetics and Personal Care
        • Fashion
        • Food & Beverages
        • Furniture and Furnishings
        • Home Improvement
        • Household, Consumer & Cosmetics
        • Household Products
        • Jewelry
        • Non-Alcoholic Beverages
        • Office Products
        • Organic Food
        • Product Recalls
        • Restaurants
        • Retail
        • Supermarkets
        • Toys
        • View All Consumer Products & Retail

        • Entertain­ment & Media

        • Advertising
        • Art
        • Books
        • Entertainment
        • Film and Motion Picture
        • Magazines
        • Music
        • Publishing & Information Services
        • Radio & Podcast
        • Television
        • View All Entertain­ment & Media

        • Health

        • Biometrics
        • Biotechnology
        • Clinical Trials & Medical Discoveries
        • Dentistry
        • FDA Approval
        • Fitness/Wellness
        • Health Care & Hospitals
        • Health Insurance
        • Infection Control
        • International Medical Approval
        • Medical Equipment
        • Medical Pharmaceuticals
        • Mental Health
        • Pharmaceuticals
        • Supplementary Medicine
        • View All Health

        • Sports

        • General Sports
        • Outdoors, Camping & Hiking
        • Sporting Events
        • Sports Equipment & Accessories
        • View All Sports

        • Travel

        • Amusement Parks and Tourist Attractions
        • Gambling & Casinos
        • Hotels and Resorts
        • Leisure & Tourism
        • Outdoors, Camping & Hiking
        • Passenger Aviation
        • Travel Industry
        • View All Travel

    • Policy & Public Interest
        • Policy & Public Interest

        • Advocacy Group Opinion
        • Animal Welfare
        • Congressional & Presidential Campaigns
        • Corporate Social Responsibility
        • Domestic Policy
        • Economic News, Trends, Analysis
        • Education
        • Environmental
        • European Government
        • FDA Approval
        • Federal and State Legislation
        • Federal Executive Branch & Agency
        • Foreign Policy & International Affairs
        • Homeland Security
        • Labor & Union
        • Legal Issues
        • Natural Disasters
        • Not For Profit
        • Patent Law
        • Public Safety
        • Trade Policy
        • U.S. State Policy
        • View All Policy & Public Interest

    • People & Culture
        • People & Culture

        • Aboriginal, First Nations & Native American
        • African American
        • Asian American
        • Children
        • Diversity, Equity & Inclusion
        • Hispanic
        • Lesbian, Gay & Bisexual
        • Men's Interest
        • People with Disabilities
        • Religion
        • Senior Citizens
        • Veterans
        • Women
        • View All People & Culture

    • Hamburger menu
    • Cision PRWeb provides efficient communication tools to continuously engage with target audiences across multiple online channels
    • Create a Free Account
      • ALL CONTACT INFO
      • Contact Us


        11AM ET Sunday – 8PM ET Friday

    The Holistic Sanctuary Responds to Johnson & Johnson’s Guilty Plea for Selling Risperdal Off-Label
    • USA - English


    News provided by

    The Holistic Sanctuary

    Nov 12, 2013, 13:35 ET

    Share this article

    Share toX

    Share this article

    Share toX

    Private Master Suites
    Private Master Suites
    Vimeo
    Vimeo

    Johnson & Johnson has the audacity to call itself ‘The Family Company,’ despite pleading guilty to federal crimes, violating clearly defined policies from the FDA and settling multiple civil and criminal prosecutions for billions of dollars.

    Post this

    Los Angeles, CA (PRWEB) November 12, 2013 -- The Holistic Sanctuary announces its response to the guilty plea from Johnson & Johnson’s Janssen unit for misrepresenting the use and purpose of the anti-psychotic medication Risperdal. The company’s $2.2 billion settlement with U.S. prosecutors, the largest fine for a single drug, is a consequence of its deliberate marketing of Risperdal to elderly patients with dementia for uses not approved by the U.S. Food and Drug Administration.(1) According to U.S. District Judge Timothy Savage, who presided over the hearing and admission of guilt, the company acted in a “calculated manner” with the intent to “maximize profits with no regard to risk.”(2)

    Judge Savage’s statement reflects the same concerns The Holistic Sanctuary has about Risperdal. U.S. Attorney General Eric Holder echoed these warnings by saying: “Put simply, this alleged conduct is shameful, and it is unacceptable. It displayed a reckless indifference to the safety of the American people. And it constituted a clear abuse of the public trust.”(3) Along with information compiled by the FDA, Johnson & Johnson’s actions violated FDA-approved regulations because “if a pharmaceutical manufacturer intends its drug to be used for a new use, not approved by the FDA, and introduces the drug into interstate commerce for that use, the drug is misbranded, and introduction of that misbranded drug into interstate commerce is a violation of the law.”(4)

    The FDA’s formal announcement about this criminal abuse further includes a statement from John Roth, director of the FDA’s Office of Criminal Investigations: “Our investigators devoted considerable time and resources to this case, to help ensure that pharmaceutical companies do not mislead healthcare providers and the general public about the safety and efficacy of their medicines. We stand ready to take similar action in the future, if warranted, to protect public health.”(5)

    In addition, the FDA has its own section devoted exclusively to adverse reactions to Risperdal, including the following warning: “Increased Mortality In Elderly Patients With Dementia-Related Psychosis.”(6) Other side effects or risk factors range from seizures, leucopenia (placing patients at an increased risk of serious infection) and diseases that can damage metabolism to motor impairment, tremors, vomiting and suicide.(7)

    The severity of this crisis is part of another study by Pediatrics, with coverage in the New York Times, revealing that foster children are being prescribed cocktails of powerful antipsychotic drugs just as frequently as some of the most mentally disabled boys and girls on Medicaid. Risperdal was one such drug on the list. Doctors and policy makers have substantial worries about the high rates of overall psychiatric drug use, which also includes prescriptions for Seroquel and Zyprexa, in the foster care system, which provides temporary living arrangements for 400,000 to 500,000 children and adolescents.(8)

    Still, Risperdal has a history of other legal troubles and scandals, such as a lawsuit alleging the drug causes men to grow breasts. The plaintiff in that case started taking Risperdal when he was nine years old, when the antipsychotic was not approved for use in children in the United States.(9) Forbes Magazine documents this story within the broader context of Johnson & Johnson’s 2012 decision to pay $181 million to resolve claims by 36 states promoting Risperdal for unapproved uses.(10)

    These abuses, misrepresentations and crimes are the exact opposite of The Holistic Sanctuary’s exclusive, all-natural and safe means of healing people and permanently ending addiction. In comparison, Risperdal is – despite all the reported risk factors, adverse side effects and potential for suicide among users – almost mandatory among conventional drug rehabs. A Detroit mother, as confirmed by WXYZ-TV (an ABC affiliate), was arrested and jailed for refusing to medicate her daughter with this drug.(11)

    For Johnny Tabaie, “Johnny The Healer,” (see also http://www.johnnythehealer.com/) the Founder of The Holistic Sanctuary, eradicating this threat and dependency on other prescription medications is a reality, thanks to his safe and successful solution known as the Pouyan Method. This treatment targets and repairs the root causes of addiction, restoring and rejuvenating brain cells to their pre-addictive state.

    Also, Johnny does not demonize addiction as a lifelong, incurable disease. His inspiring and emotionally powerful video testimonials from guests underscore his success, proving individuals can avoid the relapse-to-rehab revolving door of pain, agony and bankruptcy. People can view these powerful stories at: theholisticsanctuary.com/Ibogaine-Videos/.

    “Johnson & Johnson has the audacity to call itself ‘The Family Company,’ which is their official slogan, despite pleading guilty to federal crimes, violating clearly defined policies from the FDA and settling multiple civil and criminal prosecutions for billions of dollars. With that pattern of abuse, verified by solid reportage from mainstream news outlets like Forbes and the New York Times, Risperdal is, in my professional analysis, a disaster disguised as a drug. It is, sadly, one of many such prescription medications with serious complications and a heightened risk of death. Johnson & Johnson should be punished more aggressively, in my opinion, for such misdeeds,” says Mr. Tabaie.

    Prospective guests can see the ultimate evidence of The Holistic Sanctuary’s achievements involving the healing of the brain by clicking Pouyan Method Brain Scans (theholisticsanctuary.com/Brain-Scan/).

    About The Holistic Sanctuary

    The Holistic Sanctuary is the home of the exclusive, all-natural and proprietary Pouyan Method, which enables patients to permanently end a variety of addictions. Unlike conventional drug and alcohol rehabilitation centers, which have rates or failure or relapse among patients, The Holistic Sanctuary offers a customized protocol with the amenities of a 5-star resort. We seek to stop addiction without prescription medication or the use of 12-step programs. Nor do we classify patients as victims of an incurable disease. Our therapies focus on healing the brain, so a patient can heal their life. For more information about our innovative techniques, founding principles and testimonials from former patients, please visit http://www.theholisticsanctuary.com.

    1. bloomberg.com/news/2013-11-07/janssen-pleads-guilty-to-selling-risperdal-off-label.html; ("Janssen Pleads Guilty to Selling Risperdal Off-Label"), May 7, 2013.
    2. Ibid.
    3. buffalonews.com/city-region/federal-court/whistle-blowers-expose-huge-drug-company-scam-20131104; ("Whistle-blowers expose huge drug company scam"), November 4, 2013.
    4. fda.gov/newsevents/newsroom/pressannouncements/ucm373499.htm; ("FDA: Janssen Pharmaceuticals, Inc. to plead guilty and pay over $1.6 billion to resolve allegations of misbranding and filing false claims for its schizophrenia drug Risperdal"), November 4, 2013.
    5. Ibid.
    6. accessdata.fda.gov/drugsatfda_docs/label/2010/020272S-055S-058S-061S-062lbl.pdf; ("Highlights of Prescribing Information"), August 2010.
    7. Ibid.
    8. nytimes.com/2011/11/21/health/research/study-finds-foster-children-often-given-antipsychosis-drugs.html?_r=0; ("Drugs Used for Psychotics Go to Youths in Foster Care"), November 20, 2011.
    9. forbes.com/sites/edsilverman/2012/09/11/jj-sees-male-breasts-and-quickly-settles-risperdal-suit/; ("J&J Sees Male Breasts And Quickly Settles Risperdal Suit"), September 11, 2012.
    10. Ibid.
    11. wxyz.com/dpp/news/local_news/investigations/mom-who-chose-to-take-daughter-off-medication-files-lawsuit-alleges-daughter-deprived-of-prosthesis; ("Mom who chose to take daughter off medication files lawsuit, alleges daughter deprived of prosthesis"), May 10, 2012.

    The Holistic Sanctuary
    Attn: Media Relations
    info@TheHolisticSanctuary.com
    Los Angeles, California
    310-601-7805

    Johnny Tabaie, The Holistic Sanctuary, https://www.theholisticsanctuary.com, +1 310-601-7805, info@TheHolisticSanctuary.com

    Modal title

    Addiction Cure Center Paradise
    Addiction Cure Center Paradise
    World CLass Healing
    World CLass Healing
    Ocean Front Paradise The Holistic Sanctuary Healing Center
    Ocean Front Paradise The Holistic Sanctuary Healing Center
    Meet Johnny The Healer
    Meet Johnny The Healer
    The Holistic Sanctuary Healing Center
    The Holistic Sanctuary Healing Center
    Oceanfront Paradise
    Oceanfront Paradise
    Addiction Cure Center ParadiseWorld CLass HealingOcean Front Paradise The Holistic Sanctuary Healing CenterMeet Johnny The HealerThe Holistic Sanctuary Healing CenterOceanfront Paradise

    Contact PRWeb

    • 11AM ET Sunday – 8PM ET Friday
    • Contact Us

    About PRWeb

    • About PRWeb
    • Partners
    • Partnership Programs
    • Editorial Guidelines
    • Resources

    Why PRWeb

    • Why PRWeb
    • How It Works
    • Who Uses It
    • Pricing

    Accounts

    • Create a Free Account
    • Log in
    • Contact Us

    Do not sell or share my personal information:

    • Submit via Privacy@cision.com 
    • Call Privacy toll-free: 877-297-8921

    Contact Cision

    Products

    About

    My Services
    • All News Releases
    • Online Member Center
    • ProfNet
    Cision Distribution Helpline
    888-776-0942
    • Legal
    • Site Map
    • RSS
    • Cookie Settings
    Copyright © 2025 Cision US Inc.